We report the functional characterization of site-directed biotin binding-site mutants of recombinant core streptavidin. The mutagenesis studies were aimed at characterizing the contributions of Trp residues known to contact biotin that have been postulated to control the exceptional binding affinity observed in this system. The functional properties of single site-directed mutants replacing Trp residues with Phe or Ala at positions 79, 108, and 120 were investigated by quantitating the ECso binding parameters of these mutants to biotin and 2-iminobiotin in an ELISA format. The Streptavidin is a tetrameric protein that binds biotin with an affinity that is among the highest displayed for noncovalent interactions between a ligand and protein (Ka 1013 M-1) (1).
sible concentration range of the ELISA assay, demonstrating that these mutations lowered the K. by a factor of 104 to 106. Direct estimation of biotin K. values for W79A, W120A, and W12OF in an ultrafiltration binding assay yielded K. values of 4.3 x 107 M-1, 8.6 x 106 M-1, and >5 x 109 M-1, respectively, in excellent agreement with the ELISA estimates of AK2 with 2-iminobiotin as a reporter ligand. The results of these preliminary functional studies suggest that these aromatic side chains contribute significantly to the streptavidin-biotin binding free energy.
Streptavidin is a tetrameric protein that binds biotin with an affinity that is among the highest displayed for noncovalent interactions between a ligand and protein (Ka 1013 M-1) (1) .
Both streptavidin and the homologous protein avidin have been studied as paradigms of strong ligand-protein interactions (2) (3) (4) (5) (6) (7) (8) (9) (10) . In particular, the x-ray crystallographic studies of streptavidin by Weber et al. (9, 10) and Hendrickson et al. (11, 12) have provided considerable insight into the structural origins of the high affinity of the biotin-streptavidin system. The structure-function origins of this unusually high-affinity interaction, however, have yet to be elucidated. Streptavidin displays a number of commonly observed molecular recognition motifs in the interaction with biotin: these include hydrophobic and van der Waals dispersive interactions that are largely mediated by the aromatic side chains of Trp residues (13) (14) (15) (16) (17) (18) , hydrogen bonding networks mediated by donor/ acceptor side chains (19) (20) (21) (22) , and disorder-to-order transitions mediated by the ordering of surface polypeptide loops upon ligand binding (23) (24) (25) (26) (27) (28) (29) (30) . Miyamoto and Kollman (31, 32) have reported a computational study that emphasizes the importance of van 
der Waals and hydrophobic attractions between
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ligand and protein, as first postulated by Green (5) . Their results suggest that these interactions contribute 18 kcal/mol (1 cal = 4.184 J) to the absolute free energy of binding, while the electrostatic energy term (which includes hydrogen bonding interactions) contributes only -3 kcal/mol. In this communication, we report the design and construction of a synthetic gene for core streptavidin and initial site-directed mutagenesis studies aimed at characterizing the role of three of the Trp residues in the biotin-binding site. We have initially determined the concentration-dependent biotin and 2-iminobiotin binding isotherms of W79A/F, 108A/F, and 120A/F mutants in an ELISA assay and, independently, estimated the streptavidin-biotin Ka for the W79A, W120A, and W120F mutants. The dissection of the factors governing this interaction should provide insight into the molecular requirements for high-affinity drug design. In addition, the generation of a library of streptavidin mutants spanning a range of affinities for biotin and its derivatives will improve upon existing biotechnological applications for this widely used system (33).
METHODS
Design and Construction of Synthetic Gene. The program GCG (34) was used to generate the designed synthetic gene for core streptavidin (35), which is similar to one reported by Thompson and Weber (36) . The gene incorporates favorable Escherichia coli codon usage (37), a consensus ribosome binding site (38), an initiating methionine codon, translational stop codons, and a number of unique restriction endonuclease recognition sites. The core streptavidin gene was constructed in three segments flanked by the following restriction endonuclease recognition sites: EcoRI/Xba I, Xba I/HincII, and HincII/HindIII. Individual oligodeoxyribonucleotides were 5'-phosphorylated, annealed, and ligated into a pUC18 plasmid that had been linearized with the appropriate pair of restriction endonucleases. The three DNA segments making up the core streptavidin gene were isolated and ligated into a single pUC18 plasmid. The entire gene was subsequently sequenced to confirm the nucleotide sequence.
Site pET-21a were cultured overnight at 37°C. The cell pellet was subsequently resuspended in 10 ml of fresh Luria-Bertani medium and used to inoculate 6.5 liters of 2x YT medium supplemented with ampicillin (100 ,ug/ml) in shaker flasks.
The culture was incubated with shaking at 37°C until the OD600 reached 1.0, at which point isopropyl fB-D-thiogalactoside was added (1 mM) to induce protein expression. Cells were cultured for a further 3 h, after which they were harvested by centrifuging at 4500 x g for 10 min.
Isolation and Purification of Expressed Streptavidin and Mutants. The isolation and refolding protocols were modified from Sano and Cantor (40). The cell pellet was resuspended in 200 ml of 50 mM Tris-HCl, pH 8.0/0.75 M sucrose/i mM phenylmethylsulfonyl fluoride and ruptured by sonication. The lysed cells were incubated for 15 min with DNase I (10 ,ug/ml)/RNase A (10 Pg/ml)/MgCl2 (10 mM) and centrifuged at 22,000 x g for 30 min. The insoluble fraction was washed with 50 mM Tris HCl, pH 8.0/10 mM EDTA/1.5 M NaCl/1 mM phenylmethylsulfonyl fluoride/0.5% Triton X-100 and then washed four times without the Triton X-100 in the buffer. The inclusion bodies were dissolved in 6 M guanidine hydrochloride (500 ml, pH 1.5) to a concentration c50 ,uM (streptavidin monomer) and dialyzed against 20 liters of 50 mM Tris HCl, pH 8.0/150 mM NaCI/10 mM EDTA/0.1 mM phenylmethylsulfonyl fluoride/0.5 mM benzamidine hydrochloride for 24 h with one 20-liter change of dialysis buffer. The dialysate was centrifuged, vacuum-filtered through filters (0.45 ,um, pore size), and concentrated in a stirred ultrafiltration cell (Amicon).
WT streptavidin and the Trp -> Phe mutants were purified by affinity chromatography with iminobiotin-agarose (Pierce) (41, 42). The lowered affinity of the Trp --Ala mutants for iminobiotin precluded its use. Instead, the samples were applied to a DEAE-Sepharose FF column (1.5 x 5 cm) (Pharmacia) equilibrated with 20 mM Tris HCl (pH 7.0). Under these conditions, streptavidin does not bind to the column and is eluted in the void volume. The streptavidin-containing fractions were pooled, concentrated, equilibrated in 20 mM Tris (pH 8.5), and passed over a DEAE-Sepharose FF column (1.5 x 5 cm) equilibrated in the same buffer. Streptavidin was then eluted by applying a linear 0-0.3 M NaCl gradient.
Characterization of Streptavidin and Mutants. SDS/PAGE analysis used precast Mini-Protean 10-20% gradient gels (BioRad) with a discontinuous buffer system (43). Native PAGE was performed by omitting SDS in the sample application buffer and the gel running buffer and omitting the heat denaturation of proteins before electrophoresis. The concentration of WT streptavidin was determined by using an extinction coefficient (6280) of 34,000 M-1cm-' for the subunit (40).
Concentrations of the mutants were determined by the method of Gill and von Hippel (44) with the 8280 of WT streptavidin as reference. Protein electrospray mass spectrometry was carried out on an API-III electrospray mass spectrometer (PE Sciex, Thomhill, Ontario, Canada). The biotin-binding stoichiometry of WT streptavidin and mutants were determined in solution by the quantitative quenching in the fluorescence of fluorescein-biotin (Molecular Probes) upon titration with protein (A.C. and P.S.S., unpublished results).
ELISA Assays. A modified version of the assay reported by Bayer et al. (45) was used to quantitate the binding of biotin and 2-iminobiotin. Biotin/bovine serum albumin (BSA) (Pierce) or iminobiotin/BSA at 10 ,ug/ml was adsorbed to microtiter plates overnight at 4°C in 15 mM Na2CO3 (pH 9.6). Microtiter plates were incubated with blocking buffer at pH 8.0 or pH 10.0 (50 mM sodium phosphate, pH 8.0 or 50 mM Na2CO3, pH 10.0/100 mM NaCl/0.5% BSA/0.05% Tween 20) for at least 2 h at room temperature and then incubated in serial 1:10 dilutions of WT streptavidin or mutants starting at 100 ,ug/ml for 2 h at room temperature, rinsed with blocking buffer at pH 8.0 or pH 10.0, and incubated for 1 h at room temperature in a 1:2000 dilution of primary anti-streptavidin antibodies (Sigma) in blocking buffer at pH 8.0 or pH 10.0. The plates were rinsed thrice with blocking buffer, incubated for 1 h at room temperature in a 1:20,000 dilution of secondary anti-IgG alkaline phosphatase conjugate (Sigma) in blocking buffer, rinsed thrice with blocking buffer, and assayed for alkaline phosphatase activity at pH 10 With biotin as the ligand, the concentration-dependent binding isotherms of WT streptavidin and all Trp mutants are identical in the ELISA assay at both pH 8.0 and 10 ( Fig. 1A shows the binding isotherm of WT streptavidin and the W79A/F mutants). However, with iminobiotin/BSA as the ligand (Fig. 1B for WT streptavidin and the W79A/F mutants), the binding isotherms indicate marked differences in the affinities of WT streptavidin and the mutants, with the EC50 values in the order WT < Phe < Ala. The absolute and relative EC50 for the binding of the WT streptavidin and the Trp mutants to iminobiotin, at pH 8.0 and 10.0, are summarized in Table 1 and Fig. 2 .
These experimental results suggested that the Ala mutants should be experimentally accessible in equilibrium biotin binding assays. A spin-column assay with a 30-kDa cutoff filtration membrane was used to quantitate the partitioning of [3H]biotin between the free and bound states. While this assay is not strictly an equilibrium technique because it requires centrifugation to separate the free ligand, it does provide a useful estimate of the Ka when the affinities lie between 106 and 109 M-1. The concentration-dependent binding isotherm for W12OF was at the tight-binding limit (Ka > 109 M-1) at the lowest experimentally accessible total biotin concentration (0.2 nM) and identical to WT streptavidin (results not shown). While the W108A mutant protein proved to be unstable in this assay at the necessary concentrations, the W79A and W120A mutants yielded complete concentration-dependent binding Proc. Natl. Acad. Sci. USA 92 (1995) (1) and the Ka of _108 M-1 for iminobiotin-WT streptavidin at pH 10.0, estimated from the experimentally determined value for iminobiotin-avidin (2). These numbers are further supported by the independently determined biotin-binding affinities of the W79A and W120A mutants, which agree well with the ELISA estimates.
Our ELISA assay is insensitive to the AKa in ligand-protein binding when the Ka values are higher than _107 M-1; i.e., the ELISA binding isotherms for ligand-protein partners are indistinguishable when the Ka values are in the range of 107 to 1013 M-1. This assumption is supported by the following observations: the experimentally measured EC50 for WT streptavidin-biotin is identical to the EC50 of WT streptavidiniminobiotin at pH 10.0, despite the marked differences in the Ka of WT streptavidin-biotin (2.5 x 1013 M-1) and of iminobiotin-WT streptavidin at pH 10.0 (_108 M-1). mutants will be required to determine what proportion of these apparent binding free energy reductions can be assigned directly to side-chain binding contact interactions. It is interesting that the conservative W120F mutant displays a signiificantly reduced binding affinity relative to W79F and W108F. This result could point to a crucial role for tryptophan at this position in regulating the exceptionally slow dissociation rate of the biotin-streptavidin complex.
The analysis presented here assumes that the EC5o differences for iminobiotin reflect similar differences for biotin. This assumption is supported by the calculations of Miyamoto and Kollman (31, 32) , which suggest that the difference in the absolute free energies of binding for the two ligands is largely due to the differences in the solvation energies of the two ligands rather than large differences in ligand-protein interaction free energies. The AKa estimates from the 2-iminobiotin ELISA binding isotherms are closely corroborated by the direct estimates of the biotin Ka for the W79A, W120A, and W12OF mutants. Our results thus suggest that iminobiotin is likely to be a good reporter for intrinsic streptavidin-biotin interactions, consistent with the fact that the Trp residues do not directly interact with the structurally altered ureido moiety.
In summary, our initial mutagenesis work is consistent with the hypothesis that van der Waals and hydrophobic interactions, largely mediated by the aromatic side chains of Trp residues, are an important determinant of the binding fr e energy in the streptavidin-biotin system. These results suggest that the contribution of the Trp side chains to the absolute free energy of biotin binding are substantial, although the AKa values measured here could well include some interaction free energy contributions. These functional interpretations are also dependent on the retention of protein structure and solvent interactions with the mutant proteins.
